GSA CAPITAL PARTNERS LLP - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$110,000
-59.1%
15,996
-42.8%
0.02%
-52.8%
Q1 2022$269,000
-2.5%
27,943
+20.5%
0.04%
+2.9%
Q4 2021$276,000
-9.8%
23,193
+23.1%
0.04%
+12.9%
Q3 2021$306,00018,8360.03%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,960,046$35,195,00013.16%
MPM ASSET MANAGEMENT LLC 4,951,303$58,871,00012.72%
Atlas Venture Life Science Advisors, LLC 8,934,902$106,236,0009.76%
Logos Global Management LP 3,234,392$38,457,0003.97%
GREAT POINT PARTNERS LLC 845,000$10,047,0002.23%
Deep Track Capital, LP 2,292,250$27,255,0001.92%
Octagon Capital Advisors LP 583,649$6,940,0001.35%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 476,000$5,641,0001.26%
COMMODORE CAPITAL LP 305,125$3,628,0000.84%
RA Capital Management 2,805,045$33,352,0000.59%
View complete list of DYNE THERAPEUTICS INC shareholders